Figure 3
Novel oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation. CI, confidence interval; SEE, systemic embolic event (Modified with data from ref.38, N Engl J Med 2011;365:883–891, N Engl J Med 2011;365:981–992 and N Engl J Med 2013; 369:2093–2104).

Novel oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation. CI, confidence interval; SEE, systemic embolic event (Modified with data from ref.38, N Engl J Med 2011;365:883–891, N Engl J Med 2011;365:981–992 and N Engl J Med 2013; 369:2093–2104).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close